That standard is unfortunately not universal, as many unlicensed peptides originate from laboratories in China and India with little to no traceability
It is currently in late-stage clinical trials (phase 3) and has not received a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
This combination can lead to a more significant increase in growth hormone secretion and longer-lasting effects
In India, Mounjaro is approved for weight loss as well, if your BMI is above 30, or if your BMI is 27 and above and you have clinical conditions associated with obesity
Here, we aimed to provide an overview of retatrutide's safety and effectiveness in treating obesity
We recommend developing a flexible KLOW dosage guide that accounts for these variables, allowing for iterative adjustments based on observed effects